Skip to main content
. 2018 Jan-Mar;7(1):58–60. doi: 10.4103/sajc.sajc_59_17

Figure 1.

Figure 1

Induction response of bortezomib and dexamethasone in multiple myeloma, where C2: cycle 2 and C4: cycle 4